Adenocarcinoma of the Pancreas Completed Phase 1 Trials for Gemcitabine (DB00441)

Also known as: Pancreatic adenocarcinoma / Adenocarcinoma Pancreas / Pancreas, Adenocarcinoma / Pancreas Adenocarcinoma / Adenocarcinoma of Pancreas / Adenocarcinoma, Pancreas

IndicationStatusPhase
DBCOND0029532 (Adenocarcinoma of the Pancreas)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01145456Gamma-Secretase Inhibitor RO4929097 and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid TumorsTreatment
NCT00462553Sunitinib and Gemcitabine in Treating Patients With Pancreatic Cancer or Other Solid TumorsTreatment
NCT00375310Phase I Study of Gemcitabine, Sorafenib and Radiotherapy in Patients With Unresectable Pancreatic CancerTreatment
NCT00063947Erlotinib, Gemcitabine, and Radiation Therapy in Treating Patients With Locally Advanced Unresectable Pancreatic CancerTreatment
NCT00039403UCN-01 and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic CancerTreatment
NCT00047307Flavopiridol Plus Radiation Therapy Followed By Gemcitabine Hydrochloride in Treating Patients With Locally Advanced, Unresectable Pancreatic CancerTreatment
NCT01497392Dovitinib Lactate, Gemcitabine Hydrochloride, and Capecitabine in Treating Patients With Advanced or Metastatic Solid Tumors, Pancreatic Cancer and Biliary CancersTreatment
NCT02514421Evaluation of Safety and Efficacy of Electrochemotherapy in the Treatment of Pancreatic AdenocarcinomaTreatment
NCT02045589A Phase I Dose Escalation Study of Intratumoral VCN-01 Injections With Gemcitabine and Abraxane® in Patients With Advanced Pancreatic CancerTreatment
NCT02620423Study of Pembrolizumab With REOLYSIN® and Chemotherapy in Patients With Advanced Pancreatic AdenocarcinomaTreatment
NCT01825603ADH-1, Gemcitabine Hydrochloride and Cisplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic or Biliary Tract Cancer That Cannot Be Removed by SurgeryTreatment
NCT01764477Safety and Efficacy Study of PRI-724 Plus Gemcitabine in Subjects With Advanced or Metastatic Pancreatic AdenocarcinomaTreatment
NCT02174887Biological Effect of Nab-paclitaxel Combined to Gemcitabine in Metastatic Pancreatic CancerTreatment
NCT00327327Safety Study of Imexon Plus Gemcitabine in Untreated Pancreatic AdenocarcinomaTreatment
NCT01674556Ultrasound-assisted Treatment of Inoperable Pancreatic CancerTreatment
NCT01834170EUS-guided Intratumoral Gemcitabine in Locally Advanced Unresectable Pancreatic CancerTreatment